Selecta Biosciences, Inc. (SELB) Social Stream
Selecta Biosciences Inc (SELB) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Selecta Biosciences Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
SELB's average price target has moved down $0.25 over the prior 44 weeks.
Over the past 48 weeks, SELB's average upside potential has been 128.75%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
SELB Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
SELB's average broker recommendation rating improved by 0.66 over the prior 39 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- SELB has a greater upside potential (average analyst target price relative to current price) than 289.12% of all US stocks.
- In terms of how Selecta Biosciences Inc fares relative to all US stocks, note that its average analyst price target is higher than 18.87% of that group.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Selecta Biosciences Inc's number of analysts covering the stock is higher than 205.62% of them.
- SELB has a lower variance in analysts' estimates than -100.01% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Selecta Biosciences Inc are SEEL, SBTX, and RYTM.
What is the outlook for SELB? Use POWR Ratings for clearer insight into price direction.